companydata.dkcompanydata.dk

Bionor Pharma ApS: Financial statements 2016

CVR: 36445564

Source: annual report 2016, Danish Business Authority

01/01/2016 – 31/12/2016

Bionor Pharma ApS (CVR 36445564) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 7,876,382 and a net result of DKK 724,593. Equity in the 2016 report amounted to DKK 4,401,846. The solvency ratio was 91.9%. The company had 3 employees in the financial year.

Gross Profit
DKK 7,876,382
Profit/Loss
DKK 724,593
Equity
DKK 4,401,846
Total Assets
DKK 4,789,961
Employees
3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Bionor Pharma ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2016

Gunnar Arne Flåten leaves the board of Bionor Pharma ApSNov 1, 2016

As of November 1, 2016, Gunnar Arne Flåten has left the board of directors of Bionor Pharma ApS.

Unni Hjelmaas leaves the board of Bionor Pharma ApSNov 1, 2016

As of November 1, 2016, Unni Hjelmaas has left the board of directors of Bionor Pharma ApS.

Regina Møller Andersen joins Bionor Pharma ApS as liquidatorNov 1, 2016

As of November 1, 2016, Regina Møller Andersen is registered as liquidator of Bionor Pharma ApS.

Per-Sveno Thoresen steps down as chairman of Bionor Pharma ApSNov 1, 2016

As of November 1, 2016, Per-Sveno Thoresen has stepped down as chairman of Bionor Pharma ApS.

Unni Hjelmaas steps down as adm. dir. of Bionor Pharma ApSNov 1, 2016

As of November 1, 2016, Unni Hjelmaas has stepped down as adm. dir. of Bionor Pharma ApS.

Bionor Pharma ApS enters liquidationNov 1, 2016

On November 1, 2016, Bionor Pharma ApS entered liquidation.

Bionor Pharma ApS publishes interim reportJun 14, 2016

Bionor Pharma ApS has published its interim report for the period November 15, 2014 to December 31, 2015.

Per-Sveno Thoresen joins Bionor Pharma ApS as chairmanJun 13, 2016

As of June 13, 2016, Per-Sveno Thoresen is registered as chairman of Bionor Pharma ApS.

Per-Sveno Thoresen leaves the board of Bionor Pharma ApSJun 12, 2016

As of June 12, 2016, Per-Sveno Thoresen has left the board of directors of Bionor Pharma ApS.

Per-Sveno Thoresen joins the board of Bionor Pharma ApSMay 20, 2016

As of May 20, 2016, Per-Sveno Thoresen has joined the board of directors of Bionor Pharma ApS.

About Bionor Pharma ApS

Bionor Pharma ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2014. The company has been dissolved on 6 December 2017. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named Bionor Pharma A/S and A/S STM NR. 1002. The company has 0 employees (2016). In 2016, the company reported a gross profit of DKK 7,876,382 and a net result of DKK 724,593. Equity in the 2016 report amounted to DKK 4,401,846.

Source: annual report 2016, Danish Business Authority